New York
New York
212-643-8811 ext. 327 121 West 36th Street #201 New York, NY 10018

News & Notices

Articles and Media resources

MEDIA ALERT – COMPA Symposium: Evaluating effects of new regulations and policy shifts

It has now been two years since new final, regulations from SAMHSA and the DEA regarding buprenorphine and methadone provided greater flexibilities for the treatment of Opioid Use Disorder (OUD). The Coalition of Medication-Assisted Treatment Providers and Advocates (COMPA) is hosting a full-day symposium to examine the impact of those changes—the first set of comprehensive...
Read More

Policy and Budget Agenda (September 2025)

When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Read More

COMPA Symposium on WPIX, video and print:

Providers and policymakers will analyze the implementation of 42 CFR Part 8 methadone regulations, the first major updates to patient care in Opioid Treatment Programs (OTPs) across the country in more than 20 years. Join key providers and policymakers to discuss: • How to implement changes to federal regulations in OTPs; • How to build...
Read More

New York Providers and Policymakers Meet at Symposium on Opioid Crisis and Treatment Amid Policy Changes

Providers and policymakers will analyze the implementation of 42 CFR Part 8 methadone regulations, the first major updates to patient care in Opioid Treatment Programs (OTPs) across the country in more than 20 years. Join key providers and policymakers to discuss: • How to implement changes to federal regulations in OTPs; • How to build...
Read More

Coalition of Medication-Assisted Treatment Providers and Advocates President Allegra Schorr discusses regulatory changes in New York to make medication assisted treatment more accessible and outlines the funding needs of her providers.

When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Read More

COMPA 2025 agenda focuses on Medicaid, NIMBY, and more

When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Read More
1 2 3 … 11